KMT2A and leukemia: There is no apparent effect of Necdin deficiency on the survival of recipient mice and all recipient mice transplanted with wild type or Necdin null mice died 11 weeks following transplantation (Figure 2C), suggesting that Necdin is dispensable for the initiation and/or progression of leukemia induced by MLL-AF9 in primary transplantation assays.